Maven Clinic launches Clinical Research Institute to showcase impact of digital care models
Coincides with release of first report on improving care for underserved families
Maven Clinic has launched a new clinical research institute focused on building evidence for digital women’s and family health care, alongside the release of its first Clinical Impact Report.
The Maven Clinical Research Institute is designed to formalise and expand the company’s research efforts, with the stated aim of holding virtual care to the same scientific standards as traditional healthcare.
Maven says the Institute will serve as a hub for research, insights, and partnerships examining how digital care models affect clinical outcomes, costs, and access for women and families. The company has published more than 40 peer-reviewed studies, abstracts, and real-world evidence analyses over the past decade, and the Institute is intended to bring that work under a single, more visible structure.
The effort builds on what the company describes as one of the world’s largest datasets on women’s and family health delivered through virtual care, drawn from supporting more than 28 million lives globally.
“For years, the promise of digital care has raced ahead of the proof,” said Dr. Neel Shah, Maven’s Chief Medical Officer, in the announcement.
“As digital health enters its next chapter, the Maven Clinical Research Institute will define the science that substantiates better outcomes with rigorous explanations of how they are achieved.”
Consistent benchmarks are needed
Virtual care adoption surged during the pandemic and has remained a routine part of healthcare delivery. Yet employers and health plans often lack consistent benchmarks for assessing whether digital solutions deliver meaningful improvements in outcomes, costs, or equity. Maven positions the Institute as a response to that gap, particularly within women’s and family health, where evidence bases have historically been limited.
According to the company, the Institute will focus on three core areas: expanding a public evidence base for digital women’s and family health; integrating academic, clinical, and community expertise into research and care design; and fostering partnerships across academia and industry. Maven’s Scientific and Community Advisory Boards will guide research priorities, and a Visiting Scientist program will bring academic and clinical experts into time-limited collaborations with the company.
First Clinical Impact Report
To coincide with the launch, Maven released its inaugural Clinical Impact Report: Improving Care for Underserved Families. The report examines how Maven’s virtual care model affects outcomes and costs, with a particular focus on populations that have historically been underserved.
Among the findings highlighted: Black members who met with a Maven doula at least twice had a 56 percent lower risk of cesarean delivery; LGBTQIA+ members reported reduced out-of-pocket costs, with 15 percent citing direct savings through Maven’s support. The report also links Maven’s model to earlier intervention and more personalised, culturally responsive care.
The publication follows Maven’s accreditation by the National Committee for Quality Assurance (NCQA), making it the first women’s health company to earn NCQA Health Outcomes Accreditation — a benchmark focused on equitable, high-quality care delivery.
Maven currently supports more than 28 million lives across 175 countries. The company reports outcomes including reductions in NICU admissions and cesarean rates, and fertility results achieved without assisted reproductive technology, which it says translate into cost savings for employer customers.
Founded in 2014, Maven operates as a virtual clinic spanning fertility and family building, maternity and newborn care, parenting and pediatrics, and menopause. More than 2,000 employers and health plans use the platform. The company has raised more than $425 million from investors including General Catalyst, Sequoia, and Oak HC/FT.